Most studies on cancer incidence after breast implantation have focused on
breast cancer, while the risk of cancers at other sites has been less well
investigated. We examined cancer incidence among 1,653 women who underwent
cosmetic breast implant surgery at private clinics of plastic surgery in De
nmark and 1,736 women attending the same clinics for other reasons during t
he period 1973-1995. Furthermore, we updated previously reported results am
ong 1,114 women who received implants for cosmetic indications at public ho
spitals. All women were followed for cancer through the Danish Cancer Regis
try. In comparison with the general female population, the overall standard
ized incidence ratio (SIR) for cancer among women who received implants in
private clinics was 1.65 [95% confidence interval (CI) = 1.17-2.27]. This e
levated SIR reflected increased incidence ratios for almost all major cance
r sites; however, only for non-melanoma skin cancer was there an excess of
more than 2 cases. No significant excess of cancer was observed among women
who received implants in public hospitals (SIR = 1.10, 95% CI = 0.76-1.52)
or among women attending the private clinics for other problems (SIR = 1.1
0, 95% CI = 0.78-1.52). The SIRs for breast cancer after breast implantatio
n were 1.1 (95% CI = 0.5-2.2) among private clinic patients and 0.9 (95% CI
= 0.4-1.7) among public hospital patients. The overall findings of these 2
implant cohorts and results from other investigations suggest that cancer
risk is probably not increased among women receiving cosmetic breast implan
ts. The inconsistent results for private clinics and public hospitals are l
ikely related to selection bias and confounding among the private clinic pa
tients, but our data did not permit exploration of these possibilities. Fur
ther research into the determinants of these inconsistencies is warranted.
Int. J. Cancer 88:301-306, 2000. (C) 2000 Wiley-Liss, Inc.